Rivastigmine for dementia associated with Parkinson's disease

Emre M., Aarsland D., Albanese A., Byrne E., Deuschl G., De Deyn P., ...Daha Fazla

NEW ENGLAND JOURNAL OF MEDICINE, cilt.351, sa.24, ss.2509-2518, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 351 Sayı: 24
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1056/nejmoa041470
  • Dergi Adı: NEW ENGLAND JOURNAL OF MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2509-2518
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Background: Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients.